GO
Loading...

Forest Laboratories Inc

More

  • Time to Put Money to Work: Stock Pickers Friday, 29 May 2009 | 6:55 PM ET

    We are putting cash back to work, said Ron Muhlenkamp, portfolio manager at The Muhlenkamp Fund, and Jeff Mortimer, CIO of Charles Schwab Investment Management.

  • Earnings Roundup: BK, BLK, USB, STT, & More... Tuesday, 21 Apr 2009 | 11:57 AM ET

    The slumping economy negatively impacted many smaller companies that reported earnings on Tuesday. The following are some firms that reported earnings before the opening bell:

  • Market Insider: Tuesday Look Ahead Monday, 20 Apr 2009 | 9:40 PM ET

    Markets are bracing for a landslide of earnings news Tuesday and more focus on the Treasury's bank bailout plans.

  • Dow Closes Just Shy Of 8000 Thursday, 2 Apr 2009 | 5:21 PM ET

    The Dow rallied for a third day on Thursday, and traded above 8,000 for the first time since early February on an intra-day basis.

  • Options Action: Drug Firm Sees Heavy Call Activity Thursday, 2 Apr 2009 | 1:20 PM ET

    Generic drug company Forest Labs is seeing heavy call activity amid buyout rumors.

  • Biopharma's Ma & Pa Wednesday, 4 Mar 2009 | 11:52 AM ET

    Forget about mergers and acquisitions (M & A). Think about partnerships and acquisitions or what Leerink Swann, which specializes in healthcare stock coverage, is calling "P & A."

  • Game Plan: Four Hopeful Signs for Market Friday, 23 Jan 2009 | 6:52 PM ET

    Movement in a few key sectors could give stocks a much-needed boost.

  • Analysts Explained Friday, 23 Jan 2009 | 2:25 PM ET

    Ever wonder how these people decide which stock's a buy and which is a sell? Now you know.

  • Forest Labs: Buy or Sell? Thursday, 22 Jan 2009 | 7:53 PM ET

    Depends on which analyst you believe. Find out who Cramer's siding with.

  • Pops & Drops: Staples, Honda... Wednesday, 3 Sep 2008 | 6:35 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Staples and Honda popped while Nokia and ConAgra dropped.

  • Prescriptions for Your Portfolio Wednesday, 20 Aug 2008 | 12:45 PM ET

    Scott Richter, portfolio manager of the Fifth Third Disciplined Fund, prescribes two stocks in the pharmaceuticals sector.

  • Best Trades Now: Retail, Financials, Pharma & More Monday, 28 Jul 2008 | 4:24 PM ET

    To give investors an edge, CNBC asked the market experts for their best trades now.

  • 4-Star Pharma, Cable Stocks Monday, 28 Jul 2008 | 4:18 PM ET

    Mary Jane Matts knows a few things about "up" stocks in a "down" market, and she's sharing a couple of suggestions with CNBC.

  • Market Insider: Wednesday Look Ahead Tuesday, 8 Jul 2008 | 8:02 PM ET

    The debate about whether stocks are finding a floor is gaining momentum, but traders agree it's the earnings season that will help decide the details.

  • Pops & Drops: Valero, Lehman... Friday, 18 Apr 2008 | 6:47 PM ET

    Following are the week’s biggest winners and losers. Find out why shares of Valero and Lehman popped while State Street and Wynn dropped.

  • Pops & Drops: Smithfield Foods, Las Vegas Sands... Tuesday, 15 Apr 2008 | 6:29 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Smithfield Foods and Compuware popped while Manitowoc and Las Vegas Sands dropped.

  • Forest Labs Profit Beats, But Outlook Sluggish Tuesday, 15 Apr 2008 | 9:33 AM ET

    Forest Laboratories on Tuesday posted a better-than-expected profit, but shares fell 7.5 percent as the mid-sized drugmaker projected only slightly higher full-year earnings due to expenses to improve its product line.

  • Top Managers: Value Stocks Look Promising Monday, 24 Mar 2008 | 12:42 PM ET

    The recent gyrations in the markets may have scared some investors away, but two leading  portfolio managers say there are still plenty of value stocks to be snapped up.

  • One Giant Leap for MannKind Monday, 10 Mar 2008 | 5:11 PM ET

    Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.

  • Analyst: Pfizer Should Buy Amgen or Wyeth Friday, 7 Mar 2008 | 10:48 AM ET

    I thought I was finished with the post-Pfizer analyst meeting reaction with yesterday's post, but when an extraordinarily bearish 77-page research note from Credit Suisse big pharma analyst Catherine Arnold arrived in my inbox this morning, I had to do one more installment. She thinks Pfizer should buy Wyeth or Amgen...